PIPELINE – Summary of project portfolio
Traditionally, our portfolio consists of highly collaborative projects covering DNA repair and metabolism in various stages, spanning from basic science discoveries to lead generation and clinical development. In the recent years, a second focus emerged with the NUDIX family and several other targets such as kinases and transferases. Furthermore, singular smaller projects deal with method development in chemical biology and medicinal chemistry or in silico work on whole protein families. Key to our success in demanding projects is fruitful collaboration with outstanding partners such as LCBKI, DDD, UDOPP, Kancera and the Stenmark Lab at Stockholm University.